Literature DB >> 19962662

Proliferation and tumor suppression: not mutually exclusive for Eph receptors.

Roberta Noberini1, Elena B Pasquale.   

Abstract

Eph receptors are important but controversial regulators of cancer development. A recent study reported in Cell reveals that in the intestinal epithelium, EphB2 enhances proliferation through a kinase-dependent pathway and inhibits migration independent of its kinase activity. These separate pathways simultaneously promote proliferation but suppress invasive growth of intestinal adenomas.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19962662     DOI: 10.1016/j.ccr.2009.11.008

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  11 in total

1.  Eph/ephrin interactions modulate muscle satellite cell motility and patterning.

Authors:  Danny A Stark; Rowan M Karvas; Ashley L Siegel; D D W Cornelison
Journal:  Development       Date:  2011-11-09       Impact factor: 6.868

2.  EphB2 activity plays a pivotal role in pediatric medulloblastoma cell adhesion and invasion.

Authors:  Arend H Sikkema; Wilfred F A den Dunnen; Esther Hulleman; Dannis G van Vuurden; Guillermo Garcia-Manero; Hui Yang; Frank J G Scherpen; Kim R Kampen; Eelco W Hoving; Willem A Kamps; Sander H Diks; Maikel P Peppelenbosch; Eveline S J M de Bont
Journal:  Neuro Oncol       Date:  2012-06-21       Impact factor: 12.300

Review 3.  Role of Eph/ephrin tyrosine kinase in malignant glioma.

Authors:  Mitsutoshi Nakada; Yutaka Hayashi; Jun-ichiro Hamada
Journal:  Neuro Oncol       Date:  2011-08-19       Impact factor: 12.300

Review 4.  Cancer and Microenvironment Plasticity: Double-Edged Swords in Metastasis.

Authors:  Xueqian Zhuang; Hao Zhang; Guohong Hu
Journal:  Trends Pharmacol Sci       Date:  2019-05-08       Impact factor: 14.819

5.  CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway.

Authors:  Casey Trimmer; Diana Whitaker-Menezes; Gloria Bonuccelli; Janet N Milliman; Kristin M Daumer; Andrew E Aplin; Richard G Pestell; Federica Sotgia; Michael P Lisanti; Franco Capozza
Journal:  Cancer Res       Date:  2010-08-13       Impact factor: 12.701

6.  Investigation of the interactions between the EphB2 receptor and SNEW peptide variants.

Authors:  Buyong Ma; Stephanie Kolb; Michael Diprima; Molleshree Karna; Giovanna Tosato; Qiqi Yang; Qiang Huang; Ruth Nussinov
Journal:  Growth Factors       Date:  2014-11-20       Impact factor: 2.511

7.  EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia.

Authors:  Sara Charmsaz; Kirrilee Beckett; Fiona M Smith; Claudia Bruedigam; Andrew S Moore; Fares Al-Ejeh; Steven W Lane; Andrew W Boyd
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

8.  High expression of erythropoietin-producing hepatoma cell line-B2 (EphB2) predicts the efficiency of the Qingyihuaji formula treatment in pancreatic cancer CFPAC-1 cells through the EphrinB1-EphB2 pathway.

Authors:  Yong-Qiang Hua; Zhen Chen; Zhi-Qiang Meng; Hao Chen; Jian-Gang Shen; Kun Wang; Wang Peng; Ye-Hua Shen; Lu-Ming Liu
Journal:  Oncol Lett       Date:  2014-05-12       Impact factor: 2.967

9.  Ubiquitin ligase SPSB4 diminishes cell repulsive responses mediated by EphB2.

Authors:  Fumihiko Okumura; Akiko Joo-Okumura; Keisuke Obara; Alexander Petersen; Akihiko Nishikimi; Yoshinori Fukui; Kunio Nakatsukasa; Takumi Kamura
Journal:  Mol Biol Cell       Date:  2017-09-20       Impact factor: 4.138

10.  Slow release of oxygen from carbamide peroxide for promoting the proliferation of human brain microvascular endothelial cells under hypoxia.

Authors:  Xiangrui Meng; Yuanyuan Sun; Lan Wang; Yuhao Li; Ruizhuo Ouyang; Ping Yuan; Yuqing Miao
Journal:  Ann Transl Med       Date:  2021-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.